Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Bioconjugate Chemistry|March 30, 2023
Lysine-Derived Charge-Altering Releasable Transporters: Targeted Delivery of mRNA and siRNA to the LungsTimothy R Blake, Ole A W Haabeth, Adrienne Sallets, et al.
Journal for Immunotherapy of Cancer|December 28, 2020
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphomaSattva S Neelapu, Sherry Adkins, Stephen M Ansell, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
An mRNA SARS-CoV-2 vaccine employing Charge-Altering Releasable Transporters with a TLR-9 agonist induces neutralizing antibodies and T cell memoryOle A W Haabeth, Julian J K Lohmeyer, Adrienne Sallets, et al.
Blood|January 4, 2011
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodiesHolbrook E Kohrt, Roch Houot, Matthew J Goldstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2017
T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor SignalingSarah E Josefsson, Kanutte Huse, Arne Kolstad, et al.
Pageof 17